Jyong Biotech Ltd.
$2.31
▲
7.46%
2026-04-21 08:07:00
jyongbio.com
NGM: MENS
Explore Jyong Biotech Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$185.51 M
Current Price
$2.31
52W High / Low
$67 / $1.43
Stock P/E
—
Book Value
$-0.31
Dividend Yield
—
ROCE
35.69%
ROE
8.55%
Face Value
—
EPS
$-0.04
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
—
Beta
—
Debt / Equity
-0.5
Current Ratio
0.62
Quick Ratio
0.02
Forward P/E
—
Price / Sales
—
Enterprise Value
$196.86 M
EV / EBITDA
-109.19
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Xilio Therapeutics, Inc. | $8.45 | — | $49.46 M | — | -42.66% | -1.33% | $16.52 / $6.47 | $7.79 |
| 2. | enGene Therapeutics Inc. | $8.53 | — | $571.42 M | — | -65% | -46.07% | $12.25 / $2.65 | $4.2 |
| 3. | Vivani Medical, Inc. | $1.51 | — | $127.82 M | — | -84.04% | -1.6% | $1.92 / $0.92 | $0.21 |
| 4. | Incyte Corporation | $97.69 | 15.26 | $19.46 B | — | 24.67% | 29.87% | $112.29 / $56.13 | $26.04 |
| 5. | Revolution Medicines, Inc. | $143.09 | — | $30.24 B | — | -57.28% | -58.07% | $155.7 / $34 | $8.28 |
| 6. | MeiraGTx Holdings plc | $10.53 | — | $857.63 M | — | -86.95% | -3.68% | $11.85 / $4.55 | $-0.07 |
| 7. | Passage Bio, Inc. | $6.25 | — | $37.44 M | — | -110.08% | -1.14% | $20 / $5.12 | $5.89 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -2.06 M | -2.8 M | -2.83 M | -2.4 M |
| Net Profit | -3.02 M | -4.4 M | -6.63 M | -4.2 M |
| EPS in Rs | -0.04 | -0.06 | -0.09 | -0.06 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 6.37 M | 8.25 M | 8.74 M | 9.43 M |
| Total Liabilities | 42.88 M | 42.32 M | 38.38 M | 32.76 M |
| Equity | -36.52 M | -34.07 M | -29.63 M | -23.32 M |
| Current Assets | 0.21 M | 1.84 M | 2.46 M | 2.65 M |
| Current Liabilities | 12.13 M | 14.26 M | 12.91 M | 6.29 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -3.62 M | -2.6 M | -2.97 M | -1.98 M |
| Investing CF | 0 M | 0.1 M | 1.39 M | -1.31 M |
| Financing CF | 1.99 M | 2.03 M | 3.33 M | -1.38 M |
| Free CF | -3.62 M | -2.6 M | -3.22 M | -2.12 M |
| Capex | — | — | -0.25 M | -0.14 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 31.39% | 33.63% | -57.93% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.